BioSpace News Archive

Horizon Therapeutics plc (Nasdaq: HZNP) announced today a series of data presentations that demonstrate KRYSTEXXA® (pegloticase injection) can be co-prescribed with three commonly used immunomodulators in rheumatology to potentially help more people with chronic gout refractory to conventional therapies

Proscia®, a leading provider of AI-enabled digital pathology solutions, today announced that UNITY Biotechnology, Inc., a company developing therapeutics to extend health span by slowing, halting, or reversing diseases of aging, has deployed the Concentriq® digital pathology platform to advance its research and development (R&D) pipeline.

June 3, 2020 12:05 UTC SPERTILITY™ is an ex vivo sperm enhancement treatment currently being investigated in an ongoing clinical trial (NCT04142112) for couples using Assisted Reproductive Technology (ART) Pre-clinical data in mice demonstrated percentage of hyperactivated sperm more than doubled, yielding a three-fold increase in births via IVF and a five-fold increase in births via IUI Previously published clinical data shows the correlation between increased

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference at 1:00 p.m. ET Thursday, June 4, 2020. A live webcast of the presentation will be available on the investor relations page of the company’s corporate website at https://ir.aldeyra.com . After the live webcast, the e

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that it will host a program titled “Medical-Legal Issues in the Era of COVID-19” on June 18 at 3:00 p.m. Eastern time.

BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer; Henry Fuchs, M.D., President, Worldwide Research & Development; and Brian Mueller, Acting Chief Financial Officer, will participate in the Jefferies Virtual Healthcare Conference on June 4, 2020 at 4:00pm ET and the Goldman Sachs 41st Annual Global Healthcare Conference on June 9, 2020 at 2:10pm ET.

The New 10 minute Antibody Test from Access Medical Labs sets a new standard after the CDC announced antibody testing may be wrong 50% of the time

Tenax Therapeutics, Inc. announced that it received notice from The Nasdaq Stock Market, LLC on June 2, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.

Calyxt, Inc. announced that its high oleic low linolenic soybean has been deemed a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service, an agency of the United States Department of Agriculture.

Maverick Therapeutics Announces Pipeline Updates for its Conditionally Active T Cell Engaging COBRA ™ Platform at the Jefferies Virtual Global Healthcare Conference - MVC-101 is an EGFR x CD3 COBRA for the treatment of patients with EGFR-expressing solid tumor cancers via weekly dosing - - MVC-280 is a B7H3 x CD3 COBRA for the treatment of patients with B7H3-expressing solid tumor cancers via weekly dosing - - Both programs are scheduled for cli